The Containerised Molecular Laboratory (CML) is a concept that was advanced by the Zamstar Study.
Results of this large scale study were presented at the 42nd World Conference on Lung and Health in Lille, France during October of 2011. The study intervention, lasting three years during 2006 to 2009, used five Containerised Tuberculosis Laboratories, contributing to reduce tuberculosis by 22%. Overall contamination levels of specimens were 5.8%, very low. Thorough training of laboratory staff and safe, working infrastructure, in the form of CML’s, are regarded as key aspects of this low contamination levels.
The CML was commissioned as an addition to existing laboratory infrastructure, giving the research team exceptional control over the quality of sample processing. For more information on this study please go to: http://www.tbhiv-create.org/about/studies/ZAMSTAR